Neuropsychopharmacol Rep June 2023 PMID 36811273

Management of unspecified anxiety disorder: Expert consensus.

Hitoshi Sakurai, Ken Inada, Yumi Aoki, Masahiro Takeshima, Kenya Ie, Morito Kise, Eriko Yoshida, Takashi Tsuboi, Hisashi Yamada, Hikaru Hori, Yasushi Inada, Eiji Shimizu, Kazuo Mishima, Koichiro Watanabe, Yoshikazu Takaesu

Download social card

Mentions

Peak: 2 in Feb 2023

across 2 sources since Feb 2023

Extended reach

301

potential audience

Total likes

Video views

Mentions per month

Feb 2023 – Oct 2023

Where it's discussed

X / Twitter2 posts
YouTube1 videos

AI synopsis

What people are saying

Discussions highlight the significance of the article by noting it offers practical recommendations in the absence of official guidelines, with phrases like 'important to consider' and 'clinical relevance.' The tone combines curiosity and cautious optimism, emphasizing the potential for improving management strategies.

AgreementModerate agreement

Most discussions seem to agree that the article offers a practical approach due to lack of formal guidelines, emphasizing the importance of nonpharmacological treatments.

InterestModerate interest

Participants show moderate interest, engaging with key points like lifestyle changes and the omission of benzodiazepines, but not overly excited.

EngagementModerate engagement

Comments often reflect thoughtful reflections and questions about clinical application, indicating genuine but mild engagement.

ImpactModerate impact

The consensus suggests the publication could influence practice by encouraging clinicians to consider alternative treatments for anxiety disorders.

Abstract in brief

Expert consensus indicates that there are no officially published treatment guidelines for unspecified anxiety disorder, so field experts developed their own recommendations based on clinical questions.
Nonpharmacological treatments such as psychoeducation, lifestyle changes, relaxation techniques, and coping strategies are considered first-line options, while benzodiazepine anxiolytics are not.
When benzodiazepines are ineffective or need to be discontinued, switching to SSRIs or using nonpharmacological methods is highly recommended, with no first-line options identified for ongoing benzodiazepine use. ]

Read the full abstract

All mentions

Managing Unspecified Anxiety Disorder: Expert Recommendations

Expert consensus provides treatment recommendations for unspecified anxiety disorder, emphasizing nonpharmacological approaches like psychoeducation, lifestyle changes, relaxation, and coping strategies, with limited…

Medicine RTCL TV · Oct 7, 2023 66 views

Neuropsychopharmacology Reports (NPPR)

@NPPR_JSNP · X

New Article: Management of unspecified anxiety disorder: Expert consensus https://t.co/Mf4dpFKTMR

Feb 23, 2023 · 2 likes · 187 followers View post →

琉球大学の研究成果

@RyukyusUniv · X

Management of unspecified anxiety disorder: Expert consensus : https://t.co/X6GdDBhTaC

Feb 22, 2023 · 48 followers View post →